A detailed history of Jpmorgan Chase & CO transactions in Repligen Corp stock. As of the latest transaction made, Jpmorgan Chase & CO holds 193,499 shares of RGEN stock, worth $27 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
193,499
Previous 169,190 14.37%
Holding current value
$27 Million
Previous $31.1 Million 21.61%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$120.0 - $182.95 $2.92 Million - $4.45 Million
24,309 Added 14.37%
193,499 $24.4 Million
Q1 2024

May 10, 2024

BUY
$170.78 - $208.42 $1.4 Million - $1.71 Million
8,186 Added 5.08%
169,190 $31.1 Million
Q4 2023

Feb 12, 2024

SELL
$114.17 - $185.35 $2.4 Million - $3.89 Million
-20,989 Reduced 11.53%
161,004 $28.9 Million
Q3 2023

Nov 14, 2023

SELL
$138.78 - $176.51 $4.55 Million - $5.79 Million
-32,782 Reduced 15.26%
181,993 $28.9 Million
Q2 2023

Aug 11, 2023

BUY
$138.42 - $180.31 $860,695 - $1.12 Million
6,218 Added 2.98%
214,775 $30.4 Million
Q1 2023

May 18, 2023

BUY
$154.26 - $198.1 $13.7 Million - $17.6 Million
88,771 Added 74.11%
208,557 $35.1 Million
Q1 2023

May 11, 2023

SELL
$154.26 - $198.1 $18.6 Million - $23.9 Million
-120,790 Reduced 50.21%
119,786 $20.2 Million
Q4 2022

Feb 13, 2023

SELL
$162.42 - $220.56 $1.12 Million - $1.52 Million
-6,902 Reduced 2.79%
240,576 $40.7 Million
Q3 2022

Nov 14, 2022

SELL
$160.42 - $256.21 $2.02 Million - $3.23 Million
-12,593 Reduced 4.84%
247,478 $46.3 Million
Q2 2022

Aug 11, 2022

BUY
$140.68 - $188.02 $636,717 - $850,978
4,526 Added 1.77%
260,071 $42.2 Million
Q1 2022

May 11, 2022

SELL
$161.19 - $257.96 $3.33 Million - $5.33 Million
-20,678 Reduced 7.49%
255,545 $48.1 Million
Q4 2021

Feb 10, 2022

SELL
$247.59 - $304.47 $8.93 Million - $11 Million
-36,087 Reduced 11.55%
276,223 $73.2 Million
Q3 2021

Nov 12, 2021

BUY
$194.77 - $324.21 $60.8 Million - $101 Million
312,310 New
312,310 $90.3 Million

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $7.74B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.